Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAKR.L Share News (AKR)

  • There is currently no data for AKR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Miners Recover, Rolls-Royce And IMI Down

Fri, 13th Nov 2015 10:30

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.
----------
FTSE 100 - WINNERS
----------
Anglo American, up 2.2%, BHP Billiton, up 1.6%, Glencore up 0.6%, and Rio Tinto, up 0.5%. Miners were recovering from heavy share price falls seen on Thursday. Thursday's sell-off stemmed from a combination of weak Chinese economic data, hawkish remarks by US Federal Reserve Board members, and a fall in the price of copper and oil, with mining and oil-related stocks among the heaviest fallers.
----------
FTSE 100 - LOSERS
----------
Rolls-Royce Holdings, down 3.1%. The engineer's price target was downgraded by both Societe Generale and S&P Capital IQ following its profit warning on Thursday. On Thursday, the group delivered a comprehensively gloom-trodden outlook for 2016, while tabling plans for a massive restructuring and saying it will be reviewing its dividend policy as it foresees further headwinds its marine and aerospace businesses in 2016.
----------
FTSE 250 - WINNERS
----------
Auto Trader Group, up 3.2%. The digital automotive marketplace operator proposed a maiden interim dividend and reiterated confidence in meeting its expectations for its full financial year, as it reported a sharp jump in pretax profit in the first half due to a significant reduction in finance costs. It proposed a maiden interim dividend of 0.5 pence following its listing on the London Stock Exchange in March. For the half year to end-September, Auto Trader reported a pretax profit of GBP74.7 million, multiplying from GBP13.1 million a year before, as revenue rose to GBP138.2 million from GBP127.5 million. The leap in profit was primarily the result of a GBP46.2 million reduction in finance costs as Auto Trader benefited from a lower level of debt than under its previous private ownership, and with that debt less expensive.

Galliford Try, up 2.4%. The housebuilding and construction company said market conditions remain strong for all of its business, and it remains confident on its outlook for the current financial year. Galliford Executive Chairman Greg Fitzgerald, in a statement to be given to the company's annual general meeting, said trading in the current financial year to the end of June 2016 has been good, and it remains confident on meeting its expectations for this year and on delivering its strategy out to 2018.
----------
FTSE 250 - LOSERS
----------
IMI, down 3.5%. The valve maker following a number of negative broker ratings changes. JP Morgan has downgraded the engineer to Neutral from Overweight, cutting its price target to 930 pence from 1,100p, while Societe Generale has lowered its recommendation on the company to Hold from Buy, slashing its price target to 975 pence from 1,350p. Deutsche Bank, meanwhile, has retained its Hold recommendation, but cut its price target to 1,170p from 1,250p. On Thursday, IMI said, based on trading in the year to date, organic revenue and margins will improved in the second half of 2015 against the first but will be lower year-on-year, leaving the group's adjusted earnings per share set to come in at the low end of market expectations.
----------
MAIN MARKET AND AIM - WINNERS
----------
Japan Residential Investment Co, up 32%. The Japanese residential real estate investor said it has reached an agreement to be acquired by a unit of real estate and private equity investor Blackstone for GBP152.6 million. Blackstone, which will acquire the Japanese-focused residential property investor through Nikko II, a newly-incorporated bidding vehicle, will pay 72.00 pence per share for the company. Japan Residential also said it has received another approach valuing the company at the same amount which may or may not lead to an offer. Discussions with this potential rival suitors are at an early stage and the possible bidder is carrying out due diligence.

Fusionex International, 8.0%. The software provider has inked a strategic partnership deal with technology giant Dell Inc to offer Big Data Analytics services in the Asia region. The deal will combine Fusionex's advanced Big Data Analytics software, GIANT, with Dell's enterprise stack of infrastructure products.
----------
MAIN MARKET AND AIM - LOSERS
----------
DCD Media, down 31%. The television distribution and production company warned challenging trading conditions will likely hit earnings for its production division in 2016, as ITV PLC has opted not to commission a third season of game show 'Celebrity Squares'. Whilst 'Celebrity Squares' might be re-commissioned in the future, DCD noted, the loss of revenue from this production will hit its performance in 2016. However the company stressed that it is "encouraged by its strong pipeline of opportunities in the production division".

Akers Biosciences, down 13%. The firm warned that it expects to post a larger loss for 2015 and a lower cash balance, as its overall outlook for the year is "wholly dependant" on the company obtaining and fulfilling a number of "substantial orders" for its PIFA Heparin/PF4 Rapid Assay test products. Akers noted that this approval will be a catalyst for further orders, and this combined with a resurgence of demand in the EU for alcohol breathalysers will drive a "significantly stronger fourth quarter" than all three quarters of 2015 so far.
----------

By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
8 Oct 2018 13:10

Akers Biosciences appoints chief executive after settling legal battle

(Sharecast News) - Akers Biosciences appointed Howard Yeaton as chief executive on Monday as the company reached a settlement in its legal dispute with Pulse Health.

Read more
15 Aug 2018 08:04

Akers Biosciences profits hit over antigen difficulties

(Sharecast News) - Akers Biosciences' losses burgeoned as second-quarter revenues were cut in half after softer sales of its flagship Heparin rapid assay products had offset a stronger showing in its breathalyser unit.

Read more
3 Apr 2018 13:45

Akers Biosciences 2017 Revenue Rises But Loss Widens On Higher Costs

LONDON (Alliance News) - Akers Biosciences Inc on Tuesday said revenue grew in 2017, but its loss widened due to increased costs across the business.The AIM-listed firm

Read more
16 Mar 2018 18:11

Akers Biosciences Nets USD49,000 From Warrants Exercise (ALLISS)

LONDON (Alliance News) - Akers Biosciences Inc, a developer of health screening and testing products, said Friday that it has netted USD48,750 from warrants to

Read more
16 Feb 2017 08:44

Akers Biosciences gains US patent for disposable cartridge

(ShareCast News) - Akers Biosciences, a developer of rapid health information technologies, has been granted a US patent for its wellness disposable markers. The US Patent and Trademark Office has given a patent for its proprietary cartridge for the optical scanning device used in the company's Brea

Read more
10 Jan 2017 12:06

Akers Biosciences to raise $2m in US placing

(ShareCast News) - Rapid diagnostic test manufacturer Akers Biosciences said it plans to issue $2m of new shares plus warrants over another $1m worth of shares. The AIM- and Nasdaq-listed outfit said funds will be used for working capital as well as to accelerate growth in the US and in internationa

Read more
19 Dec 2016 14:52

Akers Biosciences signs three year deal with US hospital group

(ShareCast News) - Rapid health information technology developer Akers Biosciences announced on Friday it has signed a three-year agreement with the Greater New York Hospital Association to introduce its flagship rapid tests for heparin-induced thrombocytopenia across the association's network of ov

Read more
12 Dec 2016 16:03

UK Shareholder Meetings Calendar - Next 7 Days

Read more
1 Dec 2016 12:13

Akers Agrees Deal For First Check To Sell Cholesterol Test In US

Read more
10 Nov 2016 09:46

Akers Biosciences gains European patent for ketone breath device

(ShareCast News) - Akers Biosciences, a developer of rapid health information technologies, gains a European patent for its ketone acid breath device. The European Patent Office has issued a patent covering the company's breath ketone detector, a breath device to monitor ketone levels, which follows

Read more
19 Aug 2016 12:18

Akers Biosciences, ChubeWorkx settle lengthy legal dispute

(ShareCast News) - Akers Biosciences has reached a settlement agreement with former distributor ChubeWorkx Guernsey Ltd, allowing it to recover $1.25m in product and cash and end a lengthy legal dispute between the pair. ChubeWorkx would recover what it was owed from a promissory note by taking deli

Read more
18 Aug 2016 07:22

Akers Says Test Results "Highly Successful" For BreathScan OxiChek

Read more
30 Jun 2016 08:56

Akers Says Rapid Chlamydia Test Trial "Highly Successful"

Read more
27 Jun 2016 08:16

Akers Biosciences Signs First Distribution Deal For BreathScan OxiChek

Read more
26 May 2016 16:27

DIRECTOR DEALINGS: Akers Biosciences Chief Executive Buys First Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.